Literature DB >> 29118924

Effects of targeted CD97 immune epitopes small interference RNA on cellular biological behaviors in MDA-MB231 malignant breast cancer cell line.

Hua Tian1, Yang Chen1, Jian-Gang Zhao1, Da-Ren Liu1, Wei-Hua Gong1, Li Chen1, Yu-Lian Wu1, Jian-An Wang1.   

Abstract

Two CD97 immune epitopes, CD97EGF (epidermal growth factor domain) and CD97Stalk (stalk domain), have different distribution patterns in malignant epidermal tumors. However, little is known about the effect of CD97EGF and CD97Stalk immune epitopes in breast cancer metastasis. To explore the effects on cell proliferation, infiltration, apoptosis, and the cell cycle, we used small interfering RNA (siRNA) against CD97EGF and CD97Stalk immune epitopes to knock down CD97 in MDA-MB231 breast cancer cells. Compared with controls, CD97 knockdown caused decreased cell growth, proliferation, migration, infiltration, and altered distribution of the percentage of cells in G0/G1 and S phase. We suggest that the potential mechanism of CD97EGF and CD97Stalk immune epitopes on the biological behaviors of MDA-MB231 breast cancer cells may be related to the altered number of N-terminal glycosylation sites, which influence the stability and signaling intensity of CD97 heterodimers.

Entities:  

Keywords:  CD97; Immune epitopes; breast cancer; small interfering RNA (siRNA)

Year:  2017        PMID: 29118924      PMCID: PMC5666071     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  24 in total

1.  The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma.

Authors:  Shao-Liang Han; Chang Xu; Xiu-Ling Wu; Jun-Lin Li; Zhi Liu; Qi-Qiang Zeng
Journal:  Int J Colorectal Dis       Date:  2010-03-26       Impact factor: 2.571

2.  Site-specific N-glycosylation regulates the GPS auto-proteolysis of CD97.

Authors:  Cheng-Chih Hsiao; Kai-Fong Cheng; Hsin-Yi Chen; Yi-Hua Chou; Martin Stacey; Gin-Wen Chang; Hsi-Hsien Lin
Journal:  FEBS Lett       Date:  2009-09-06       Impact factor: 4.124

3.  Experimental study on inhibition of the growth of human adenoid cystic cancer cells by RNA interference targeting against survivingene.

Authors:  Xin Wang; Yu Xiong; Congji Zhang; Jixiang Zhou; Jun Yang; Kun Wang; Xiyan Xia
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Regulation of CD97 protein in thyroid carcinoma.

Authors:  C Hoang-Vu; K Bull; I Schwarz; G Krause; C Schmutzler; G Aust; J Köhrle; H Dralle
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

Review 5.  Regulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancer.

Authors:  Jia Zhang; Hongmei Yao; Ge Song; Xia Liao; Yao Xian; Weimin Li
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

6.  Expression characteristics of the human CD97 antigen.

Authors:  W Eichler; J Hamann; G Aust
Journal:  Tissue Antigens       Date:  1997-11

Review 7.  Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination.

Authors:  Jason S L Yu; Wei Cui
Journal:  Development       Date:  2016-09-01       Impact factor: 6.868

Review 8.  CD97 is a multifunctional leukocyte receptor with distinct roles in human cancers (Review).

Authors:  Michael Safaee; Aaron J Clark; Michael E Ivan; Michael C Oh; Orin Bloch; Matthew Z Sun; Taemin Oh; Andrew T Parsa
Journal:  Int J Oncol       Date:  2013-08-22       Impact factor: 5.650

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55.

Authors:  Rachel J M Abbott; Ian Spendlove; Pietro Roversi; Hannah Fitzgibbon; Vroni Knott; Peter Teriete; James M McDonnell; Penny A Handford; Susan M Lea
Journal:  J Biol Chem       Date:  2007-04-20       Impact factor: 5.157

View more
  3 in total

Review 1.  The Emerging Role of Adhesion GPCRs in Cancer.

Authors:  Abanoub A Gad; Nariman Balenga
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-13

2.  Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer.

Authors:  Ioanna-Maria Orfanou; Orestis Argyros; Andreas Papapetropoulos; Sofia Tseleni-Balafouta; Konstantinos Vougas; Constantin Tamvakopoulos
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

3.  ELTD1 promotes invasion and metastasis by activating MMP2 in colorectal cancer.

Authors:  Jiawei Sun; Zizhen Zhang; Jingyu Chen; Meng Xue; Xia Pan
Journal:  Int J Biol Sci       Date:  2021-07-13       Impact factor: 6.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.